Major Drivers Propelling the Growth oh theTrigeminal Neuralgia Treatment Market Forward: Rising Prevalence Of Neurological Disorders Fuels Demand For Market
Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.
What Is the Estimated Market Size of the Trigeminal Neuralgia Treatment Market In 2029?
In the recent past, the market for trigeminal neuralgia treatment has seen significant growth. The market size is projected to increase from $0.68 billion in 2024 to $0.73 billion in 2025, experiencing a compound annual growth rate (CAGR) of 7.1%. The surge during the historic period can be linked to the mounting occurrence of chronic illnesses, rising instances of neurological disorders and trigeminal neuralgia, escalating demand for treatments that are minimally invasive, and a heightened need for surgeries that follow the same principle.
The market size of treatments for trigeminal neuralgia is predicted to experience considerable expansion in the coming years, reaching a value of $0.95 billion in 2029 with a compound annual growth rate (CAGR) of 6.7%. This rise during the projected period can be credited to the enhanced comprehension of trigeminal neuralgia among medical staff and ordinary citizens, a surge in TN cases, an expanding elderly population, escalating healthcare spending, and a growth in identified cases. Predominant trends in the predicted period comprise of developments in neuromodulation procedures, progress in TENS technology, enhancements in medicinal exploration and technology, embracement of minimally invasive surgical methods, and progresses in digital health technologies.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21307&type=smp
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Trigeminal Neuralgia Treatment Market?
The surge in instances of neurological conditions is predicted to fuel the expansion of the market for trigeminal neuralgia treatments. Neurological conditions are those that impact the nervous system, encompassing the brain, spinal cord, and nerves. The surging incidence of such disorders can be linked to several causes such as genetic susceptibility, infection, trauma, toxic substances, autoimmune reactions, and deterioration. The treatment of trigeminal neuralgia aids patients with neurological diseases by alleviating intense facial discomfort, minimizing nerve inflammation, improving life quality, assisting in pain management, and averting additional neurological damage. For example, in April 2022, the Belgium-based non-profit organization, the European Brain Council, stated that more than 600 neurological diseases and approximately 300 psychiatric conditions afflict millions worldwide, including 65 million individuals with epilepsy. In Europe, there are 10.5 million people suffering from dementia, and this figure is predicted to increase to 18.7 million by 2050. Hence, the escalating occurrence of neurological disorders is projected to spur the growth of the trigeminal neuralgia treatment market.
Which Key Market Segments Comprise the Trigeminal Neuralgia Treatment Market and Drive Its Revenue Growth?
The trigeminal neuralgia treatment market covered in this report is segmented –
1) By Treatment Type: Medications, Surgery, Other Treatment Types
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
3) By End-User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Medications: Anticonvulsants, Muscle Relaxants, Antidepressants
2) By Surgery: Microvascular Decompression Surgery, Gamma Knife Radiosurgery, Rhizotomy
3) By Other Treatment Types: Nerve Blocks, Stereotactic Radiosurgery, Physical Therapy
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=21307&type=smp
Which Areas Are Leading Regions in the Trigeminal Neuralgia Treatment Market Expansion Across the Globe?
North America was the largest region in the trigeminal neuralgia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the trigeminal neuralgia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Key Market Trends in theTrigeminal Neuralgia Treatment Market Over the Coming Years?
Leading corporations in the trigeminal neuralgia treatment market are concentrating on submitting new drug (IND) applications to gain approval from relevant authorities and subsequently enlarge their market presence. The submission of an investigational new drug (IND) application is a request by a pharmaceutical firm to regulatory bodies for clearance to commence human trials of a new drug, with the intended purpose of determining its safety, efficacy, and proper dosage. For example, Noema Pharma, a Swiss-based biotech firm in its clinical stage, obtained an Investigational New Drug (IND) application in February 2022 from the US government’s Food and Drug Administration (FDA) for the commencement of a Phase 2b clinical trial of the mGluR5 inhibitor NOE-101 in trigeminal neuralgia (TN), using LibraTN. The LibraTN is a twenty-four-week, multicentre, placebo-controlled study aiming to evaluate the effectiveness and safety of NOE-101 in adults with TN-associated pain. The findings of this study are projected to be available in the first half of 2024. Furthermore, the FDA has granted a fast track designation to basimglurant (NOE-101) to fast-track its development and evaluation.
View the full report here:
How Is the Trigeminal Neuralgia Treatment Market Conceptually Defined?
Trigeminal neuralgia treatment involves medical strategies to manage the severe, sharp facial pain caused by trigeminal neuralgia, which affects the trigeminal nerve. The main goal of trigeminal neuralgia treatment is to alleviate pain, reduce the frequency and intensity of episodes, and address the underlying nerve irritation, ultimately enhancing the patient’s quality of life.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21307
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
